Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects

Journal of the American Pharmacists Association

Volumn 43, Issue 1, 2003, Pages 50-55

  Mangum, Stacy A ^a   Kraenow, Kim R ^a   Narducci, Warren A ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Nishna Valley Pharmacy   (United States)

Author keywords

Ambulatory care; Community pharmacy; Counseling; Hypertension; Patient education; Screening; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; EDUCATION; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT REFERRAL; PHARMACY; UNITED STATES;

ADULT; AGED; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; HYPERTENSION; INTERNSHIP, NONMEDICAL; IOWA; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION;

EID: 0037270245     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/10865800360467042     Document Type: Article

References (14)

1. The Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-46.
2. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2001.
3. American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2000.
4. National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. Hypertension. 1993;23:275.
5. Schommer JC. Pharmacist workload and time management. Drug Topics. February 19, 2001:45.
6. McKenney JM, Slining JM, Henderson HR, et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973;48:1104-11.
7. McKenney JM, Brown ED, Necsary R, et al. Effect of pharmacist drug monitoring and patient education on hypertensive patients. Contemp Pharm Pract. 1978:1:50-6.
8. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc. 1996;36:443-51.
9. Monroe WP, Kunz K, Dalmady-Israel C, et al. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther. 1997;19:113-23.
10. Carter BL, Barnette DJ, Chrischilles E, et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997;17:1274-85.
11. The Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-83.
12. Somerville S, Somerville J, Croft P, Lewis M. Atrial fibrillation: a comparison of methods to identify cases in general practice. Brit J Gen Pract. 2000;50:727-9.
13. McDonough RP, Rovers JP, Currie JD. Obstacles to the implementation of pharmaceutical care in the community setting. J Am Pharm Assoc. 1998;38:87-95.
14. Campbell RK. Confronting barriers to pharmaceutical care. J Am Pharm Assoc. 1998;38:410-2.